eTMS for Veterans and First Responders With PTSD
- Conditions
- Post Traumatic Stress Disorder
- Interventions
- Device: Electroencephalogram personalized Transcranial Magnetic Stimulation (eTMS)
- Registration Number
- NCT06294106
- Brief Summary
A battery of physiological and behavioral data will be collected before and after application of eTMS. Participants will be veterans or first responders diagnosed with PTSD. Study will be a double-blind, sham-controlled, parallel group, randomized clinical trial.
- Detailed Description
Veterans and first responders diagnosed with PTSD will be studied to evaluate safety and efficacy of an EEG personalized TMS paradigm. All participants will undergo 2 days of extensive testing prior to eTMS application and 2 days of testing after. Testing will include MRI, OPM, EEG, behavioral tasks, questionnaires, and an EEG sleep study.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
- Veteran or first responder
- diagnosed with post-traumatic stress disorder with PCL-5 cutoff of 31 or above
- Claustrophobia
- Contraindications to MRI
- Pregnant
- Uncontrolled medical, psychological, or neurological conditions
- Unable to calculate EEG alpha frequency
- History of ECT or rTMS
- History of intracranial lesion or increased intracranial pressure
- History of stroke
- History of other neurologic conditions
- Family history of epilepsy
- Personal history of epilepsy
- certain medications
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description eTMS Electroencephalogram personalized Transcranial Magnetic Stimulation (eTMS) The active side of a TMS coil will be used to administer eTMS application. eTMS sham Electroencephalogram personalized Transcranial Magnetic Stimulation (eTMS) The sham side of a TMS coil will be used to administer a sham dosage of eTMS application.
- Primary Outcome Measures
Name Time Method Adverse Events Up to 7 weeks Adverse event reports (or lack-of) will determine device safety
Report of Symptoms Up to 7 weeks Symptom questionnaire to be completed before and after all study procedures to determine feasibility in this patient population. Various symptoms will be rated on a likert scale from absent to severe.
- Secondary Outcome Measures
Name Time Method PCL-5 Up to 7 weeks Completion of the PTSD symptom questionnaire. Scores range from 0-80, with a PTSD cutoff score of 31.
OPM 1 session 1 week pre treatment and 1 session 1 week post treatment Optically Pumped Magnetometry signals collected at rest and during basic tasks to assess neuropathways of activation
EEG Up to 7 sessions collected over 7 weeks. Electroencephalography recordings at rest and during a stress task. Specifically analyzing the P300.
fMRI 1 session 1 week pre treatment and 1 session 1 week post treatment Functional MRI signals including BOLD signals collected at rest and during basic tasks to assess neuropathways of activation
Trial Locations
- Locations (1)
Fralin Biomedical Research Institute
🇺🇸Roanoke, Virginia, United States